Cargando…

RNA Modification by m(6)A Methylation in Cardiovascular Disease

Cardiovascular disease is currently the leading cause of death worldwide, and its underlying regulatory mechanisms remain largely unknown. N(6)-Methyladenosine (m(6)A) RNA methylation is an epigenetic modification involved in the splicing, nuclear export, translational regulation, and degradation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jun, Wei, Xiang, Yi, Xin, Jiang, Ding-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183103/ https://www.ncbi.nlm.nih.gov/pubmed/34221238 http://dx.doi.org/10.1155/2021/8813909

Ejemplares similares

N(6)-methyl-adenosine (m(6)A) in RNA: An Old Modification with A Novel Epigenetic Function
por: Niu, Yamei, et al.
Publicado: (2013)

The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases
por: Zhang, Beijian, et al.
Publicado: (2020)

N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases
por: Luan, Junjun, et al.
Publicado: (2022)

Decoding m(6)A mRNA methylation by reader proteins in liver diseases
por: Sun, Lijiao, et al.
Publicado: (2023)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2022)

Dynamic regulation and functions of mRNA m6A modification
por: Wang, Shanshan, et al.
Publicado: (2022)

Role of m(6)A RNA methylation in cardiovascular disease (Review)
por: Qin, Yuhan, et al.
Publicado: (2020)

Insights into the regulatory role of RNA methylation modifications in glioma
por: Long, Shengrong, et al.
Publicado: (2023)

Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment
por: Zhang, YanJun, et al.
Publicado: (2023)

Posttranslational Modifications in Ferroptosis
por: Wei, Xiang, et al.
Publicado: (2020)

Targeting the RNA m(6)A modification for cancer immunotherapy
por: Li, Xinxin, et al.
Publicado: (2022)

Regulatory role and mechanism of m(6)A RNA modification in human metabolic diseases
por: Zhang, Yuliang, et al.
Publicado: (2021)

M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics
por: Huang, Yurong, et al.
Publicado: (2023)

Research Progress of m(6)A RNA Methylation in Skin Diseases
por: Liu, Chang, et al.
Publicado: (2023)

The interplay between m6A RNA methylation and noncoding RNA in cancer
por: Ma, Shuai, et al.
Publicado: (2019)

Crosstalk Between Histone and m(6)A Modifications and Emerging Roles of m(6)A RNA Methylation
por: Xu, Zibin, et al.
Publicado: (2022)

Roles of RNA m6A modification in nonalcoholic fatty liver disease
por: Tan, Jian, et al.
Publicado: (2023)

Emerging role of m6A methylation modification in ovarian cancer
por: Chang, Lin-Lin, et al.
Publicado: (2021)

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022)

RNA modification in mRNA cancer vaccines
por: Mei, Yingxue, et al.
Publicado: (2023)

Metabolic Control of m(6)A RNA Modification
por: Kim, Joohwan, et al.
Publicado: (2021)

Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases
por: Sikorski, Vilbert, et al.
Publicado: (2022)

Modification of N(6)-methyladenosine RNA methylation on heat shock protein expression
por: Yu, Jiayao, et al.
Publicado: (2018)

RNA modifications in aging-associated cardiovascular diseases
por: Yang, Xinyu, et al.
Publicado: (2022)

Modification of STIM2 by m(6)A RNA methylation inhibits metastasis of cholangiocarcinoma
por: Chen, Feng-Qiu, et al.
Publicado: (2022)

The role of mRNA m(6)A methylation in the nervous system
por: Li, Jiashuo, et al.
Publicado: (2019)

The detection and functions of RNA modification m(6)A based on m(6)A writers and erasers
por: Zhang, Wei, et al.
Publicado: (2021)

RNA m(6)A methylation in cancer
por: Wang, Zhaotong, et al.
Publicado: (2022)

The role of m(6)A RNA methylation in autoimmune diseases: Novel therapeutic opportunities
por: Shan, Yunan, et al.
Publicado: (2023)

RNA m(6)A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
por: Gu, Chang, et al.
Publicado: (2020)

Histone methylation and vascular biology
por: Wei, Xiang, et al.
Publicado: (2020)

Roles of N(6)‐methyladenosine (m(6)A) RNA modifications in urological cancers
por: Wang, Xiao, et al.
Publicado: (2020)

Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues
por: Meng, Qingren, et al.
Publicado: (2023)

Histone Methylation and Oxidative Stress in Cardiovascular Diseases
por: Yi, Xin, et al.
Publicado: (2022)

Emerging roles of m6A RNA modification in cancer therapeutic resistance
por: Liu, Wei-Wei, et al.
Publicado: (2023)

Dynamic m(6)A modification regulates local translation of mRNA in axons
por: Yu, Jun, et al.
Publicado: (2018)

Recent advances in dynamic m(6)A RNA modification
por: Cao, Guangchao, et al.
Publicado: (2016)

Regulation of Gene Expression by m6Am RNA Modification
por: Cesaro, Bianca, et al.
Publicado: (2023)

RNA modification m(6)Am: the role in cardiac biology
por: Benak, Daniel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sfdau04aljlvq98d51dee8k9m5